Kccq (original) (raw)

Latest News for: kccq

Edit

BBIO-Acoramidis-ESC-HF2026 KCCQ-improvement (BridgeBio Pharma Inc)

Public Technologies 11 May 2026

Effect of Acoramidis on Improvement or Maintenance of Heart Failure-Related Health Status as Assessed by Kansas City Cardiomyopathy Questionnaire Overall Summary (KCCQ-OS) Score in ATTRibute-CM ... KCCQ-OS score,d mean (SD).

Edit

BBIO-Acoramidis-ESC-HF2026 KCCQ-subgroups (BridgeBio Pharma Inc)

Public Technologies 11 May 2026

To evaluate the effect of acoramidis on heart failure-related health status as assessed by the Kansas City Cardiomyopathy Questionnaire Overall Summary (KCCQ-OS) score across participant subgroups from the ATTRibute-CM study (NCT03860935).

Article Search

tools

You can search using any combination of the items listed below.

Language:

Sort:

Indexed:

Search:

Duplicates: